Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.525    0.00 (0.00%)
Bid:
0.50
Ask:
0.55
Spread: 0.05 (10.00%)
Market Cap: £2.38m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Physiomics News

Physiomics Raises New Funds To "Further Develop Its Business"
27 May 2020

Physiomics Raises New Funds To "Further Develop Its Business"

Physiomics Raises New Funds To "Further Develop Its Business"

Physiomics raises £829,000 to fund further development
27 May 2020

Physiomics raises £829,000 to fund further development

(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.

Physiomics Secures Additional Contract With Bicycle Therapeutics
6 Apr 2020

Physiomics Secures Additional Contract With Bicycle Therapeutics

Physiomics Secures Additional Contract With Bicycle Therapeutics

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak
19 Mar 2020

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak

Physiomics receives 'Connect' funding award from NIHR
10 Mar 2020

Physiomics receives 'Connect' funding award from NIHR

(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Inv...

Physiomics Secures Contract Extension With Existing Client Merck
5 Mar 2020

Physiomics Secures Contract Extension With Existing Client Merck

Physiomics Secures Contract Extension With Existing Client Merck

Physiomics First Half Revenue Rises But No Grants Means Widened Loss
3 Mar 2020

Physiomics First Half Revenue Rises But No Grants Means Widened Loss

Physiomics First Half Revenue Rises But No Grants Means Widened Loss

Physiomics H1 revenues on the rise
3 Mar 2020

Physiomics H1 revenues on the rise

(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.